After finishing at $0.06 in the prior trading day, Sunshine Biopharma Inc (NASDAQ: SBFM) closed at $0.05, down -7.65%. In other words, the price has decreased by -$0.0044 from its previous closing price. On the day, 5435940 shares were traded. SBFM stock price reached its highest trading level at $0.0618 during the session, while it also had its lowest trading level at $0.0520.
Ratios:
Our goal is to gain a better understanding of SBFM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.11 and its Current Ratio is at 5.00. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.
Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 2.84M and an Enterprise Value of -15.33M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.14 while its Price-to-Book (P/B) ratio in mrq is 0.06. Its current Enterprise Value per Revenue stands at -0.75 whereas that against EBITDA is 0.59.
Stock Price History:
Over the past 52 weeks, SBFM has reached a high of $1.40, while it has fallen to a 52-week low of $0.04. The 50-Day Moving Average of the stock is 0.1712, while the 200-Day Moving Average is calculated to be 0.3417.
Shares Statistics:
The stock has traded on average 14.86M shares per day over the past 3-months and 79.32M shares per day over the last 10 days, according to various share statistics. A total of 54.45M shares are outstanding, with a floating share count of 50.34M. Insiders hold about 7.55% of the company’s shares, while institutions hold 21.60% stake in the company. Shares short for SBFM as of Feb 29, 2024 were 445.3k with a Short Ratio of 0.03, compared to 102.64k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.82% and a Short% of Float of 0.88%.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.16 and -$0.16 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is $0.09, with 1 analysts recommending between $0.09 and $0.09.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $44.4M in the next fiscal year. The high estimate is $44.4M and the low estimate is $44.4M. The average revenue growth estimate for next year is up 97.20% from the average revenue estimate for this year.
